Loading Events

« All Events

  • This event has passed.

Hepatitis C New Treatment Course

Sat 29th June @ 10:00 am

Are you one of the many GPs who have patients with hepatitis C in your practice but have not prescribed any hepatitis C treatment yet? This comprehensive course in the new hepatitis C direct acting antivirals aims to increase confidence in hepatitis C management and treatment through interactive case discussions facilitated by experts in the field. The PBS listing of new pangenotypic regimens is simplifying treatment selection even further. Elimination of hepatitis C in Australia will require increased access to treatment in a variety of settings, including primary care, Sexual Health, Aboriginal Medical Services and alcohol and other drug services.

MORE INFORMATION

Register at:
http://www.ashm.org.au/training/

Registrations Close:
Monday, 24 June 2019

For further details contact:
Michelle Kwok
T 02 8204 0723
E michelle.kwok@ashm.org.au

DATE:
Sat 29th June


TIME:
10:00 am - 4:00 pm


VENUE:
North Sydney Harbourview Hotel
17 Blue St
North Sydney NSW 2060
View map
RACGP CPD POINTS:
This activity has been approved by RACGP QI&CPD Program. Total (40) Category 1 CPD Points.

SPEAKERS:

Dr Brett Jones
Gastroenterologist, Royal North Shore Hospital

Dr Thao Lam
Gastroenterologist and Specialist in Addiction Medicine, Westmead Hospital

Dr David Baker
General Practitioner, East Sydney Doctors, Darlinghurst

TARGET AUDIENCE:

GPs, other Medical Practitioners & Nurse Practitioners working in General Practice, Aboriginal Health, Drug and Alcohol and Correctional settings, who wish to prescribe HCV treatment independent of specialist approval.

LEARNING OUTCOMES:
  • Screen at risk patients, order and interpret tests appropriately to diagnose chronic hepatitis C infection
  • Perform the recommended baseline assessment including assessing liver disease severity and screening for potential drug-drug interactions, evaluate patient treatment readiness and manage any associated comorbidities
  • Explain approved antiviral treatment options and duration of therapy for all HCV genotypes based on prior treatment experience and cirrhotic status
  • Prescribe HCV antiviral therapy in accordance with PBS patient and prescriber eligibility criteria
  • Recognise risk factors, clinical signs, symptoms and complications of advanced liver disease and manage or refer to specialist care appropriately
COST:
This course is FREE. Lunch and refreshments will be provided.

ENQUIRIES:

Judy or Robi, Education Coordinators – 9432 8250 or events@snhn.org.au.


REGISTRATION IS MANDATORY FOR ATTENDANCE.